Advancing Subject Diversity to Strengthen Clinical Trial Quality and Equity

At iGlobal Clinical Research, we are deeply committed to fostering Diversity, Equity, and Inclusion (DEI) in clinical trials. Ensuring diverse representation in research populations is not just an ethical imperative but a scientific necessity. By prioritizing DEI in clinical trials, we can generate more robust data, better understand treatment effects across all populations, and deliver meaningful therapeutic solutions to those most impacted by disease.

Our comprehensive DEI strategy spans protocol design, site selection, subject outreach, and site support, creating an ecosystem where diverse populations are authentically included in clinical research.

Why Diversity Matters in Clinical Trials

By promoting subject diversity in clinical trials, we aim to:

• Enhance Scientific Insights: Increase the chance of identifying critical findings that inform disease mechanisms and treatment development.
• Ensure Equity in Treatment: Understand how therapies work in populations most impacted by diseases.
• Protect Data Integrity: Generate inclusive, high-quality datasets that reflect real-world populations.

Our DEI Strategy: A Holistic Approach to Inclusion

1. Study Design with Inclusivity in Focus

Building Accessible and Inclusive Protocols

• Inclusivity in Protocols: Designing protocols that reflect the needs of diverse populations, including race, ethnicity, older adults, LGBTQ communities, and rural populations.
• Accessibility-Focused Study Designs: Leveraging decentralized and hybrid trial models or implementing technology alternatives to reduce geographic and logistical barriers.
• Logistical Adaptations: Addressing frequency of visits, transportation challenges, and financial barriers to participation.
• CRO Staff Training: Equipping iGlobal staff with DEI-focused recruitment strategies and sensitivity to diverse populations.

2. Selecting Diversity-Oriented Sites and Investigators

Partnering with Culturally Aligned Investigators

• Geographic Location: Identifying sites in regions where the disease is prevalent and diverse populations are accessible.
• Cultural Competency: Partnering with PIs and staff who reflect or understand the cultural backgrounds of target populations.
• Community Partnerships: Engaging sites with relationships in trusted local networks, including churches, schools, and community centers.

To evaluate site readiness, iGlobal utilizes its proprietary Diversity Site Assessment Tool (DSAT) to assess sites’ capacity to engage diverse populations and provide actionable feedback for improvement.

3. Empowering Sites to Drive DEI Success

Providing Education, Resources, and Recognition

• Educational Materials: Study materials that represent diverse groups, with translation services and multilingual content available.
• DEI Training Programs: Cultural competency training for site staff, ensuring alignment with diversity-focused recruitment goals.
• Community Engagement: Supporting sites in hosting health fairs, screenings, and educational events to build local trust.
• Diversity Champions: Encouraging sites to designate team members as “Diversity Champions” to lead DEI efforts.
• Recognition Programs: Acknowledging sites that achieve excellence in enrolling diverse populations.

4. Subject Outreach & Community Engagement

Building Trust and Bridging Gaps

• Culturally Relevant Materials: Educational resources, FAQs, and safety information designed to resonate with diverse audiences.
• Family & Caregiver Inclusion: Encouraging the involvement of family members in consent discussions and study updates to build confidence.
• Reducing Participant Burden: Incorporating decentralized trial elements, such as telehealth, home visits, and travel assistance through iGlobal Patient Concierge Services.
• Community Partnerships: Collaborating with trusted local entities like churches, schools, grocery stores, and pharmacies to connect with patients.
• Community Leader Engagement: Soliciting input from local leaders to align study goals with community needs and priorities.

The iGlobal Commitment to DEI

• Unified Collaboration: DEI requires a shared commitment from sponsors, CROs, investigators, and sites. iGlobal fosters a collaborative approach to drive inclusion at every level.
• Tailored Strategies: By leveraging our proprietary tools, such as the Diversity Site Assessment Tool (DSAT), and employing community-centric approaches, we ensure our DEI initiatives are data-driven and impactful.
• Continuous Improvement: We remain dedicated to refining our strategies through ongoing feedback, analysis, and innovation.

Partner with iGlobal Clinical Research to advance diversity, equity, and inclusion in clinical trials—ensuring better outcomes for all.